ASX:CSL CSL (CSL) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About CSL Stock (ASX:CSL) 30 days 90 days 365 days Advanced Chart Get CSL alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume869,289 shsAverage VolumeN/AMarket CapitalizationA$77.43 billionP/E Ratio28.02Dividend Yield1.56%Price TargetN/AConsensus RatingN/A Company Overview CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Read More Receive CSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter. Email Address CSL Stock News HeadlinesCSL LEON APPROVES FUNDING LCS3 hours ago | msn.comAustralia's CSL to consolidate R&D at six sitesJuly 15 at 11:28 PM | reuters.com“All the land that you see I will give to you and your offspring forever…”“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 trillion vault of untapped American wealth. Former CIA advisor Jim Rickards calls it the “Old Testament Wealth Code” — and says it could transform your financial future. He’s revealing everything in a new presentation.July 18 at 2:00 AM | Paradigm Press (Ad)When will CSL shares finally catch a break?July 15 at 11:28 PM | msn.comAustralia's CSL eyes reduction of one-third of R&D workforce, AFR reportsJuly 14, 2025 | msn.comThe 858 CSL That BMW Never BuiltJuly 14, 2025 | msn.comAustralia's CSL plans to cut one-third of R&D workforce, AFR reportsJuly 14, 2025 | msn.comBMW M2 CS Versus BMW M4 CSL, Compact Thrills Meet Track DominanceJuly 13, 2025 | msn.comSee More Headlines CSL Stock Analysis - Frequently Asked Questions How were CSL's earnings last quarter? CSL Limited (ASX:CSL) issued its quarterly earnings data on Wednesday, August, 14th. The company reported $4.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $4.22 by $0.01. CSL had a trailing twelve-month return on equity of 15.37% and a net margin of 18.41%. What other stocks do shareholders of CSL own? Based on aggregate information from My MarketBeat watchlists, some other companies that CSL investors own include Cochlear (COH), Mineral Resources (MIN), ResMed (RMD), Magellan Financial Group (MFG), NIB (NHF), Accent Group (AX1) and Corporate Travel Management (CTD). Company Calendar Last Earnings8/14/2019Today7/18/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Biotechnology Sub-IndustryRubber And Plastic Products Current SymbolASX:CSL CIKN/A Webwww.csl.com.au Phone+61-3-93891911FaxN/AEmployees12,500Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$7.88 Trailing P/E Ratio28.02 Forward P/E RatioN/A P/E Growth1.29Net IncomeA$2.64 billion Net Margins18.41% Pretax MarginN/A Return on Equity15.37% Return on Assets6.56% Debt Debt-to-Equity Ratio64.46 Current Ratio1.86 Quick Ratio1.68 Sales & Book Value Annual SalesA$14.80 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow207.70 Book ValueA$42.52 per share Price / BookN/AMiscellaneous Outstanding Shares484,210,000Free FloatN/AMarket CapA$77.43 billion OptionableNot Optionable Beta0.32 (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (ASX:CSL) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CSL Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share CSL With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.